missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PIK3CA/PIK3R1 (p110 alpha/p85 alpha) Recombinant Human Protein
PIK3CA (p110 alpha) is known to be involved in the PI 3-kinase/AKT signaling pathway.
Marque: Invitrogen™ PV4788
Code nomenclature Nacres: NA.28
Informations supplémentaires : Poids : 0.50000kg
Description
PIK3CA (p110 alpha) is known to be involved in the PI 3-kinase⁄AKT signaling pathway, which plays an important role in regulating cell growth and apoptosis. PIK3CA is coexpressed and copurified with the regulatory subunit PI3KR1.Spécification
| NP_003209.2 ⁄ NP_852664.1 | |
| 128.4⁄83.6 kDa | |
| PIK3CA/PIK3R1 (p110 alpha/p85 alpha), PI3 Kinase alpha | |
| Yes | |
| Biochemical binding/kinetic, Biochemical ADP accumulation | |
| Dry Ice | |
| His (N-Terminal)⁄None | |
| phosphoinositide-3-kinase, catalytic, alpha polypeptide | |
| Kinases & Inhibitors | |
| Liquid | |
| Kinase Assay | |
| Signal Transduction |
| 5290 | |
| 20 µg | |
| PI3 Kinase Family | |
| His Tag | |
| Lipid Kinases | |
| Adapta™ | |
| PIK3CA/PIK3R1 | |
| Baculovirus | |
| Full Length, Recombinant | |
| Lipid Kinases | |
| Human |